2006
DOI: 10.1089/ars.2006.8.1597
|View full text |Cite
|
Sign up to set email alerts
|

NADPH Oxidases in the Kidney

Abstract: NADPH oxidases have a distinct cellular localization in the kidney. Reactive oxygen species (ROS) are produced in the kidney by fibroblasts, endothelial cells (EC), vascular smooth muscle cells (VSMC), mesangial cells (MCs), tubular cells, and podocyte cells. All components of the phagocytic NADPH oxidase, as well as the Nox-1 and -4, are expressed in the kidney, with a prominent expression in renal vessels, glomeruli, and podocytes, and cells of the thick ascending limb of the loop of Henle (TAL), macula dens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

11
407
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 436 publications
(419 citation statements)
references
References 76 publications
11
407
0
1
Order By: Relevance
“…Our results showed that G6PD activity, NADPH and GSH levels in the Cur group were higher than in the DC group. These results are similar to the previous descriptions [48][49][50][51][52].…”
Section: Discussionsupporting
confidence: 93%
“…Our results showed that G6PD activity, NADPH and GSH levels in the Cur group were higher than in the DC group. These results are similar to the previous descriptions [48][49][50][51][52].…”
Section: Discussionsupporting
confidence: 93%
“…Angiotensin II stimulates nicotinamide adenine dinucleotide phosphate (NADPH) oxidase expression that induces the production of reactive oxygen species, and triggers inflammatory response. [25][26][27][28] In this study, we found that aliskiren reduced oxidative stress and IL-6 expression in non-infarcted area similarly to valsartan with our tested doses. In addition, the combination of valsartan and aliskiren further suppressed oxidative stress and IL-6 expression in non-infarcted area than either monotherapy.…”
Section: Discussionsupporting
confidence: 60%
“…Increased oxidative stress in diabetic nephropathy could be attributed to an imbalance between ROS production and its removal capacity. Although multiple enzymatic pathways have been implicated in the generation of ROS in hyperglycaemia, NOX might be an important ROS source in diabetic kidney [32]. In particular, NOX-4 levels were shown to increase early in the STZ-induced diabetic rat model and NOX inhibition prevented diabetic changes of kidney [30,31,33].…”
Section: Discussionmentioning
confidence: 99%